目錄肽產(chǎn)品
CPEP-001A
C-Peptide, human
Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln
Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln
Size：0.5
P1(RMB)：490
MW：3020.3
One letter sequence：EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ
Molecular Formula：C129H211N35O48
Description：This C-peptide measurement can sensitively assess β-cell functions under standardized conditions, which is the most suitable primary outcome for clinical trials of therapies aimed at preserving or improving preserving endogenous insulin secretion in type 1 diabetes patients.
Literature Reference：A.S.C. Ko and D.G. Smyth, Eur. J. Biochem., 20, 190 (1971)\nP.E. Oyer et al., J. Biol. Chem., 246, 1375 (1971)\nK. Igano et al., Bull. Chem. Soc. Jpn., 54, 3088 (1981)
Cas：[33017-11-7]
P1(RMB)：490
MW：3020.3
One letter sequence：EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ
Molecular Formula：C129H211N35O48
Description：This C-peptide measurement can sensitively assess β-cell functions under standardized conditions, which is the most suitable primary outcome for clinical trials of therapies aimed at preserving or improving preserving endogenous insulin secretion in type 1 diabetes patients.
Literature Reference：A.S.C. Ko and D.G. Smyth, Eur. J. Biochem., 20, 190 (1971)\nP.E. Oyer et al., J. Biol. Chem., 246, 1375 (1971)\nK. Igano et al., Bull. Chem. Soc. Jpn., 54, 3088 (1981)
Cas：[33017-11-7]
-
ADD杭州市錢塘區(qū)12號大街69號
-
TEL0571-86737011
-
E-mail
Copyright ? 2024 中肽生化有限公司 All Rights Reserved.
浙ICP備05051877號-1
業(yè)務(wù)咨詢和客戶服務(wù)
企業(yè)微信公眾號
